• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为致癌性主转录因子的IRF4

IRF4 as an Oncogenic Master Transcription Factor.

作者信息

Wong Regina Wan Ju, Ong Jolynn Zu Lin, Theardy Madelaine Skolastika, Sanda Takaomi

机构信息

Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.

出版信息

Cancers (Basel). 2022 Sep 2;14(17):4314. doi: 10.3390/cancers14174314.

DOI:10.3390/cancers14174314
PMID:36077849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9454692/
Abstract

IRF4 is a transcription factor in the interferon regulatory factor (IRF) family. Since the discovery of this gene, various research fields including immunology and oncology have highlighted the unique characteristics and the importance of IRF4 in several biological processes that distinguish it from other IRF family members. In normal lymphocyte development and immunity, IRF4 mediates critical immune responses via interactions with upstream signaling pathways, such as the T-cell receptor and B-cell receptor pathways, as well as their binding partners, which are uniquely expressed in each cell type. On the other hand, IRF4 acts as an oncogene in various mature lymphoid neoplasms when abnormally expressed. IRF4 induces several oncogenes, such as , as well as genes that characterize each cell type by utilizing its ability as a master regulator of immunity. IRF4 and its upstream factor NF-κB form a transcriptional regulatory circuit, including feedback and feedforward loops, to maintain the oncogenic transcriptional program in malignant lymphoid cells. In this review article, we provide an overview of the molecular functions of IRF4 in mature lymphoid neoplasms and highlight its upstream and downstream pathways, as well as the regulatory circuits mediated by IRF4.

摘要

IRF4是干扰素调节因子(IRF)家族中的一种转录因子。自该基因被发现以来,包括免疫学和肿瘤学在内的各个研究领域都强调了IRF4在若干生物学过程中的独特特征及其重要性,这些生物学过程使其有别于其他IRF家族成员。在正常淋巴细胞发育和免疫过程中,IRF4通过与上游信号通路(如T细胞受体和B细胞受体通路)及其在每种细胞类型中独特表达的结合伙伴相互作用,介导关键的免疫反应。另一方面,IRF4在异常表达时,在各种成熟淋巴细胞肿瘤中充当癌基因。IRF4通过利用其作为免疫主调节因子的能力,诱导多种癌基因,如 ,以及表征每种细胞类型的基因。IRF4及其上游因子NF-κB形成一个转录调节回路,包括反馈和前馈环,以维持恶性淋巴细胞中的致癌转录程序。在这篇综述文章中,我们概述了IRF4在成熟淋巴细胞肿瘤中的分子功能,并强调了其上游和下游途径,以及由IRF4介导的调节回路。 (注:原文中“such as ”后面内容缺失)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9454692/b98fc9e4ffd6/cancers-14-04314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9454692/b98fc9e4ffd6/cancers-14-04314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9454692/b98fc9e4ffd6/cancers-14-04314-g001.jpg

相似文献

1
IRF4 as an Oncogenic Master Transcription Factor.作为致癌性主转录因子的IRF4
Cancers (Basel). 2022 Sep 2;14(17):4314. doi: 10.3390/cancers14174314.
2
Lineage- and Stage-Specific Oncogenicity of IRF4.IRF4 的谱系和阶段特异性致癌性。
Exp Hematol. 2022 Oct;114:9-17. doi: 10.1016/j.exphem.2022.07.300. Epub 2022 Jul 29.
3
The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.致癌转录因子IRF4在外周T细胞淋巴瘤中受新型CD30/NF-κB正反馈环调控。
Blood. 2015 May 14;125(20):3118-27. doi: 10.1182/blood-2014-05-578575. Epub 2015 Apr 1.
4
BATF-JUN is critical for IRF4-mediated transcription in T cells.BATF-JUN 对于 T 细胞中 IRF4 介导的转录至关重要。
Nature. 2012 Oct 25;490(7421):543-6. doi: 10.1038/nature11530. Epub 2012 Sep 19.
5
Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.干扰素调节因子4和干扰素共有序列结合蛋白在巨噬细胞中的差异表达及不同功能
J Immunol. 1999 Sep 1;163(5):2713-22.
6
Essential role of interferon regulatory factor 4 (IRF4) in immune cell development.干扰素调节因子4(IRF4)在免疫细胞发育中的重要作用。
Arch Pharm Res. 2016 Nov;39(11):1548-1555. doi: 10.1007/s12272-016-0854-1. Epub 2016 Nov 9.
7
Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma.IRF4 和 NF-κB 驱动的成人 T 细胞白血病/淋巴瘤中的前馈调节环。
Blood. 2020 Mar 19;135(12):934-947. doi: 10.1182/blood.2019002639.
8
Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.卡波西肉瘤相关疱疹病毒在原发性渗出性淋巴瘤中驱动超级增强子介导的存活基因表达程序。
mBio. 2020 Aug 25;11(4):e01457-20. doi: 10.1128/mBio.01457-20.
9
Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance.生发中心迁移阶段由B细胞转录因子共表达和相对丰度定义。
J Immunol. 2006 Nov 15;177(10):6930-9. doi: 10.4049/jimmunol.177.10.6930.
10
IRF4: Immunity. Malignancy! Therapy?IRF4:免疫。恶性肿瘤!治疗?
Clin Cancer Res. 2009 May 1;15(9):2954-61. doi: 10.1158/1078-0432.CCR-08-1845. Epub 2009 Apr 21.

引用本文的文献

1
IRF4 Mediates Immune Evasion to Facilitate EBV Transformation.IRF4介导免疫逃逸以促进EB病毒转化。
Viruses. 2025 Jun 24;17(7):885. doi: 10.3390/v17070885.
2
Unraveling the genetic landscape of susceptibility to multiple primary cancers.解析多种原发性癌症易感性的遗传图谱。
HGG Adv. 2025 Apr 10;6(2):100413. doi: 10.1016/j.xhgg.2025.100413. Epub 2025 Feb 4.
3
Uncovering selection pressures on the IRF gene family in bats' immune system.揭示蝙蝠免疫系统中IRF基因家族的选择压力。

本文引用的文献

1
Lineage- and Stage-Specific Oncogenicity of IRF4.IRF4 的谱系和阶段特异性致癌性。
Exp Hematol. 2022 Oct;114:9-17. doi: 10.1016/j.exphem.2022.07.300. Epub 2022 Jul 29.
2
IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphoma.IRF4 驱动 T 细胞淋巴瘤斑马鱼模型中的克隆进化和谱系选择。
Nat Commun. 2022 May 3;13(1):2420. doi: 10.1038/s41467-022-30053-9.
3
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements.成人异常表达 CD10、BCL6 和 MUM1 的弥漫性大 B 细胞淋巴瘤中富含 IRF4 重排。
Immunogenetics. 2025 Jan 7;77(1):10. doi: 10.1007/s00251-024-01367-3.
4
DFF-ChIP: a method to detect and quantify complex interactions between RNA polymerase II, transcription factors, and chromatin.DFF-ChIP:一种检测和定量 RNA 聚合酶 II、转录因子和染色质之间复杂相互作用的方法。
Nucleic Acids Res. 2024 Oct 14;52(18):e88. doi: 10.1093/nar/gkae760.
5
The Role of Interferon Regulatory Factors in Liver Diseases.干扰素调节因子在肝脏疾病中的作用。
Int J Mol Sci. 2024 Jun 22;25(13):6874. doi: 10.3390/ijms25136874.
6
Transcriptional control of metabolism by interferon regulatory factors.干扰素调节因子对代谢的转录控制。
Nat Rev Endocrinol. 2024 Oct;20(10):573-587. doi: 10.1038/s41574-024-00990-0. Epub 2024 May 20.
7
Common skin cancers and their association with other non-cutaneous primary malignancies: a review of the literature.常见皮肤癌及其与其他非皮肤原发性恶性肿瘤的关系:文献复习。
Med Oncol. 2024 May 17;41(6):157. doi: 10.1007/s12032-024-02385-7.
8
An immune-related gene prognostic prediction risk model for neoadjuvant chemoradiotherapy in rectal cancer using artificial intelligence.基于人工智能的直肠癌新辅助放化疗免疫相关基因预后预测风险模型
Front Oncol. 2024 Feb 9;14:1294440. doi: 10.3389/fonc.2024.1294440. eCollection 2024.
9
Targeting transcription factors for therapeutic benefit in rheumatoid arthritis.针对类风湿关节炎的治疗益处的转录因子。
Front Immunol. 2023 Jun 29;14:1196931. doi: 10.3389/fimmu.2023.1196931. eCollection 2023.
10
Regulatory effects of IRF4 on immune cells in the tumor microenvironment.IRF4 对肿瘤微环境中免疫细胞的调控作用。
Front Immunol. 2023 Feb 6;14:1086803. doi: 10.3389/fimmu.2023.1086803. eCollection 2023.
Blood Adv. 2022 Apr 12;6(7):2361-2372. doi: 10.1182/bloodadvances.2021006034.
4
Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption.选择性反义寡核苷酸抑制人 IRF4 通过细胞周期破坏防止恶性骨髓瘤再生。
Cell Stem Cell. 2021 Apr 1;28(4):623-636.e9. doi: 10.1016/j.stem.2020.12.017. Epub 2021 Jan 20.
5
Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma.定量表达 Ikaros、IRF4 和 PSMD10 蛋白可预测经 VRD 治疗的多发性骨髓瘤患者的生存情况。
Blood Adv. 2020 Dec 8;4(23):6023-6033. doi: 10.1182/bloodadvances.2020002711.
6
Activation of the Tec Kinase ITK Controls Graded IRF4 Expression in Response to Variations in TCR Signal Strength.Tec 激酶 ITK 的激活控制着 TCR 信号强度变化时 IRF4 的梯度表达。
J Immunol. 2020 Jul 15;205(2):335-345. doi: 10.4049/jimmunol.1900853. Epub 2020 Jun 3.
7
Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma.IRF4 和 NF-κB 驱动的成人 T 细胞白血病/淋巴瘤中的前馈调节环。
Blood. 2020 Mar 19;135(12):934-947. doi: 10.1182/blood.2019002639.
8
Molecular Genetics in the Diagnosis and Biology of Lymphoid Neoplasms.淋巴造血系统肿瘤的分子遗传学诊断与生物学
Am J Clin Pathol. 2019 Aug 1;152(3):277-301. doi: 10.1093/ajcp/aqz078.
9
Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4.鉴定骨髓瘤中来那度胺耐药途径,并使用 cereblon 替换、抑制 STAT3 或靶向 IRF4 进行靶向重敏化。
Blood Cancer J. 2019 Feb 11;9(2):19. doi: 10.1038/s41408-019-0173-0.
10
Burkitt lymphoma in Iraqi children: A distinctive form of sporadic disease with high incidence of EBV cases and more frequent expression of MUM1/IRF4 protein in cases with head and neck presentation.伊拉克儿童伯基特淋巴瘤:一种独特的散发疾病形式,其 EBV 病例发生率高,头颈部表现病例中 MUM1/IRF4 蛋白表达更频繁。
Pediatr Blood Cancer. 2018 Dec;65(12):e27399. doi: 10.1002/pbc.27399. Epub 2018 Sep 11.